Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and tolerability of oxycodone in patients with moderate to severe cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)

Snippet

Sponsor: Taiwan Mundipharma Pharmaceuticals Ltd. | Conditions: Cancer, Pain | Phase 4 | Status: COMPLETED